Page last updated: 2024-09-03

7 alpha-hydroxy-4-cholesten-3-one and Intestinal Diseases

7 alpha-hydroxy-4-cholesten-3-one has been researched along with Intestinal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeBarber, AE; Jones, PJH; Mymin, D; Myrie, SB; Othman, RA; Roullet, JB; Steiner, RD1
Aly, A; Axelson, M; Sjövall, J1

Trials

1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Intestinal Diseases

ArticleYear
Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.
    The Journal of pediatrics, 2017, Volume: 188

    Topics: Adolescent; Adult; Anticholesteremic Agents; Cholestanol; Cholestenones; Cholesterol; Ezetimibe; Female; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Phytosterols; Sitosterols; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult

2017

Other Studies

1 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Intestinal Diseases

ArticleYear
Levels of 7 alpha-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man.
    FEBS letters, 1988, Nov-07, Volume: 239, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Biomarkers; Cholestenes; Cholestenones; Cholestyramine Resin; Chromatography, High Pressure Liquid; Female; Humans; Intestinal Diseases; Liver Diseases; Male; Middle Aged

1988